Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for September 12th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 12th:

Bristol-Myers Squibb Company (BMY - Free Report) : This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Bristol-Myers Squibb Company Price and Consensus

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.38%, compared with the industry average of 2.77%. Its five-year average dividend yield is 2.67%.

Bristol-Myers Squibb Company Dividend Yield (TTM)

The AES Corporation (AES - Free Report) : This diversified power generation and utility company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.

The AES Corporation Price and Consensus

This Zacks Rank #2 (Buy) company has a dividend yield of 3.51%, compared with the industry average of 2.93%. Its five-year average dividend yield is 3.58%.

The AES Corporation Dividend Yield (TTM)

The Buckle, Inc. : This retailer of apparel, accessories and footwear has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.

Buckle, Inc. (The) Price and Consensus

This Zacks Rank #2 (Buy) company has a dividend yield of 4.75%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.95%.

Buckle, Inc. (The) Dividend Yield (TTM)

Arbor Realty Trust, Inc. (ABR - Free Report) : This real estate investment trust and national direct lender has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.

Arbor Realty Trust Price and Consensus

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 9.08%, compared with the industry average of 4.18%. Its five-year average dividend yield is 8.61%.

Arbor Realty Trust Dividend Yield (TTM)

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Bristol Myers Squibb Company (BMY) - free report >>

The AES Corporation (AES) - free report >>

Arbor Realty Trust (ABR) - free report >>